HOME >> BIOLOGY >> NEWS
After insects attack, plants bunker sugars for later regrowth

This press release is also available in German.

Using radioactive carbon and genetically modified native tobacco plants (Nicotiana attenuata), scientists at Max Planck Institutes in Jena and Golm (Potsdam) and at the Research Centre in J├╝lich have discovered the first gene mediating tolerance to herbivore attack: GAL83, the beta-subunit of Nicotiana attenuataTMs SNF-1 related kinase. This gene mediates a rapid herbivore-elicited carbon-hoarding behaviour in which recently assimilated carbon (measured with 11CO2) is squirrelled away to the roots rather than transported to young expanding leaves, to be used later to extend the period of seed and flower production when the plant is done growing. As soon as the plants are attacked by the larvae of the nicotine-resistant tobacco hornworm, Manduca sexta, elicitors from this herbivoreTMs mouth (called FACs - fatty acid conjugates), which also tune the plantTMs induced defence responses, are shown in this study to activate carbon storage in the roots. By reconfiguring where it stores carbon, the plant gains a measure of tolerance and thereby the ability to withstand voracious herbivores.

Ecological studies conducted in the department of Prof. Ian T. Baldwin at the Max Planck Institute for Chemical Ecology in Jena, Germany, focus on the defense of plants against attack from herbivores. Plants respond to attack by producing an arsenal of direct (toxins, digestibility reducers, etc.) and indirect defences that reduce the attackers' performance, thereby lessening the amount of damage inflicted to the plant. However, the co-evolutionary dynamics of the interaction often leads to herbivores that are adapted to the plantTMs defences. Resolution of this evolutionary impasse may require the kind of solution advocated by Mahatma Gandhi: tolerate the damage. Or
'"/>

Contact: Dr. Ian T. Baldwin
baldwin@ice.mpg.de
49-364-157-1101
Max-Planck-Gesellschaft
5-Sep-2006


Page: 1 2 3

Related biology news :

1. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
2. After scrutiny, preemie lung treatments turn out to be safe, effective
3. After 2 years, study shows Revlimid patients live longer and remain transfusion free
4. After North Korea test, what can be done to reduce the growing nuclear threat?
5. After the Hurricanes
6. After the yeast is gone bacteria continue to develop flavor of sparkling wine
7. After a time-shift, mixed signals from the circadian clock
8. After flu exposure, mild exercise protects mature mice from dying
9. Tropical insects go the distance to inform rainforest conservation
10. For many insects, winter survival is in the genes
11. Do we need a paradigm change? Disputing coevolution in herbivorous insects

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... PBT.U), is excited to announce the formation of ... developing preclinical ophthalmology assets through proof of concept. ... created by Portage Pharmaceuticals Limited and being developed ... surface and anterior segment diseases. This agent has ...
Breaking Biology Technology:
Cached News: